Literature DB >> 15842042

T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders.

Hong Chang1, Suzanne Kamel-Reid, Nusrat Hussain, Jeff Lipton, Hans A Messner.   

Abstract

T-cell lymphoproliferative disorders are uncommon occurrences after bone marrow transplantation (BMT). We describe 2 patients in whom a monoclonal T-cell large granular lymphocytosis (T-LGL) developed after allogeneic BMT for B-cell lymphoproliferative disorders. Both patients showed a persistent expansion of CD3+, CD8+, and CD57+ large granular lymphocytes of donor origin with clonally rearranged T-cell receptor gamma genes and no evidence of Epstein-Barr virus-related infection. The manifestations were consistent with T-LGL leukemia as defined by the World Health Organization criteria. In both patients, graft-vs-host disease developed, and 1 had recurrent episodes of cytomegalovirus viremia. The other patient had received a graft from a hepatitis C antibody-positive donor without developing any signs of hepatitis C infection. Both patients remain in complete remission from their B-cell lymphoproliferative disorders and do not have symptoms related to T-LGL leukemia. These data show that T-LGL leukemia should be included as one of the types of posttransplantation lymphoproliferative disorders that can occur after allogeneic BMT for B-cell neoplasms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15842042

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

Review 2.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

3.  Lymphocyte expansion after unrelated cord blood allogeneic stem cell transplantation in adults.

Authors:  Y Le Bris; T Guillaume; A Ménard; M Illiaquer; J Martin; S Malard; A Duquesne; P Peterlin; C Debord; N Robillard; M Eveillard; S Wuillème; J Delaunay; M Mohty; A Garnier; P Moreau; M C Béné; P Chevallier
Journal:  Bone Marrow Transplant       Date:  2017-01-30       Impact factor: 5.483

4.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

Review 5.  Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

Authors:  HeeJin Cheon; Karolina H Dziewulska; Katharine B Moosic; Kristine C Olson; Alejandro A Gru; David J Feith; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

6.  Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia.

Authors:  Dong Hwan Kim; Suzanne Kamel-Reid; Hong Chang; Robert Sutherland; Chul Won Jung; Hyeoung-Joon Kim; Je-Jung Lee; Jeffrey H Lipton
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

7.  Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β1, and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia.

Authors:  Shosaku Nomura; Tomoki Ito; Atsushi Satake; Kazuyoshi Ishii
Journal:  J Blood Med       Date:  2018-12-19

Review 8.  Large granular lymphocytosis after transplantation.

Authors:  Zhi-Yuan Qiu; Guang-Yu Tian; Zhao Zhang; Ye-Qing Zhang; Wei Xu; Jian-Yong Li
Journal:  Oncotarget       Date:  2017-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.